Two observations by reading the "new" Proxy from 09/17/08

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

gcduck

Rank: President [?]

Points: 12254 [?]

Votes: 135 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Two observations by reading the "new" Proxy from 09/17/08

posted on Sep 17, 2008 10:51PM

1. The following was in the Proxy from last week, but I oversaw it (sorry, if this was brought to the board's attention already):

The Technology Committe is no longer existing (Tredennick was Head of it)

"Effective from August 2007 until March 2008. The Technology Committee was disbanded in March 2008."

I guess, with Bibeau and Schrock as additional experts, there was no need for a Technology Committe - the whole board should be one...;-)

2. The only difference between the "old" and "new" Proxy (besides the corrected number of outstanding shares):

Helmut Falk, Jr. 3,528,231 - "new" Proxy: 3,593,231

Donald E. Schrock 104,175 - "new" Proxy: 89,822

While the increase of Schrock's shares are due to the monthly vesting options, Mr. Falk has 65.000 shares less (compared from between Aug 29th and Sep 12th) - just an observation, maybe he sold them to Crossflo...lol